LABLOL INJ 4ML

AboutLABLOL INJ 4ML, containing Labetalol, is an intravenous medication that acts as a non-selective beta-adrenergic receptor blocker and an alpha-1 adrenergic receptor blocker. This dual mechanism of action provides effective and rapid reduction in blood pressure by both decreasing peripheral vascular resistance (via alpha-1 blockade) and reducing heart rate and myocardial contractility (via beta-blockade). It is primarily used in acute hypertensive emergencies, where rapid and controlled blood pressure reduction is critical to prevent end-organ damage. Labetalol is also a preferred agent for managing severe hypertension in specific populations, such as pregnant women with pre-eclampsia or eclampsia, due to its favorable safety profile in these contexts.The administration of LABLOL INJ is typically via intravenous bolus or continuous infusion, allowing for precise titration to achieve the desired hypotensive effect. Close monitoring of blood pressure and heart rate is essential during and after administration to prevent excessive hypotension or bradycardia. Its ability to lower blood pressure without significantly compromising renal blood flow makes it a valuable tool in various acute hypertensive conditions. Healthcare professionals must carefully assess patient comorbidities, such as asthma or heart block, before administration, as these conditions may contraindicate its use due to its beta-blocking properties.UsesManagement of hypertensive emergenciesTreatment of severe hypertensionControl of blood pressure in pre-eclampsia/eclampsiaUsed in pheochromocytoma crisisDirections For UseAdministered intravenously, as a bolus or continuous infusion, by a healthcare professional. Dosage is individualized and titrated to blood pressure response.BenefitsRapidly lowers elevated blood pressureProvides dual alpha and beta blockadePreserves renal blood flowEffective in various acute hypertensive statesSuitable for use in pregnancy-induced hypertensionReduces cardiac workloadSide EffectsOrthostatic hypotension (dizziness upon standing)Dizziness and fatigueNausea and vomitingHeadacheBradycardia (slow heart rate)Bronchospasm (especially in susceptible individuals)Scalp tinglingHeart blockLiver enzyme elevationInjection site reactionsCongestive heart failure exacerbationSexual dysfunctionSafety MeasuresAlcohol - Avoid or limit alcohol consumption as it may potentiate the hypotensive effects of Labetalol.Pregnancy - Generally considered safe and often preferred for managing severe hypertension in pregnancy, including pre-eclampsia.Breastfeeding - Generally considered safe during breastfeeding; low levels are excreted in breast milk, but adverse effects on infants are rare.Liver - Use with caution in patients with severe liver impairment; metabolism may be reduced, potentially prolonging effects.Kidney - No dose adjustment is typically needed for patients with kidney impairment.Lung - Contraindicated in patients with asthma or severe chronic obstructive pulmonary disease (COPD) due to the risk of bronchospasm.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.